actinogen ltd (ACW:ASX)

Last A$0.02 AUD

Change Today 0.00 / 0.00%

Volume 0.0

ACW On Other Exchanges

Symbol

Exchange

ACW:AU

ASX

3AC:GR

Berlin

As of 8:41 PM 05/16/13 All times are local (Market data is delayed by at least 15 minutes).

actinogen ltd (ACW) Snapshot

Open A$0.02		Previous Close A$0.02
Day High A$0.02		Day Low A$0.02
52 Week High 10/5/12 - A$0.04		52 Week Low 12/27/12 - A$0.01
Market Cap 1.7M		Average Volume 10 Days 7.4K
EPS TTM A$-0.0078		Shares Outstanding 89.3M
EX-Date --		P/E TM --
Dividend --		Dividend Yield --

Current Stock Chart for ACTINOGEN LTD (ACW)

ACW:AU Historical Stock Quote
ACW:AU Advanced Stock Chart

Related News

No related news articles were found.

actinogen ltd (ACW) Related Businessweek News

No Related Businessweek News Found

actinogen ltd (ACW) Details

Actinogen Limited engages in the discovery and isolation of soil actinomycetes that are found in Western Australia. It develops various actinomycete isolates, which produce antibiotic activity primarily against Methicillin Resistant Staphylococcus Aureus (MRSA), Vancomycin Resistant Enterococci (VRE) bacteria, pathogenic gram positive anaerobic bacterium, and pathogenic Candida species. The company also develops various isolates that synthesize plant growth hormones; isolates, which are capable of tolerating saline solutions that may have application in the rehabilitation of salt affected soils; isolates that synthesize volatile antifungal chemicals, including polyenes; isolates, which can digest the starch based plastics; actinomycetes that can produce Shikimic acid for use in antiviral drugs; and isolates, which produce bioactive molecules, which are directed against the human cancer stem cells. In addition, it intends to seek commercial application for bioactive compounds produced by soil actinomycetes. The company was formerly known as Australian Biogen Limited and changed its name to Actinogen Limited in August 2007. Actinogen Limited is headquartered in Perth, Australia.

Detailed ACW:AU Company Description...

www.actinogen.com.au

actinogen ltd (ACW) Top Compensated Officers

Dr. Zhukov Pervan MB, BS(WA), FRACGP, FAICD

Executive Chairman

Total Annual Compensation: A$80.0K

Mr. David Alan Zohar BSc Dip Ed.

Executive Director

Total Annual Compensation: A$66.7K

Dr. David Keast CDA (Seale hayne agric. college, uk), BSc, MSc

Scientific Director and Director

Total Annual Compensation: A$126.7K

Executives, Board Directors

Compensation as of Fiscal Year 2012.

actinogen ltd (ACW) Key Developments

Actinogen Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2012

Feb 28 13

Actinogen Limited reported consolidated earnings results for the half year ended December 31, 2012. For the period, the company’s loss before income tax was AUD 308,180 compared to AUD 1,260,364 a year ago. Loss was AUD 17,908 compared to AUD 1,003,004 a year ago. Basic loss per share attributable to the ordinary equity holders of the company was 0.02 cents compared to 1.61 cents a year ago. Net cash inflow from operating activities was AUD 51,788 compared to net cash outflow from operating activities of AUD 653,374 a year ago.

Actinogen Limited. to Report First Half, 2013 Results on Feb 28, 2013

Feb 17 13

Actinogen Limited. announced that they will report first half, 2013 results on Feb 28, 2013

Actinogen Limited., Annual General Meeting, Nov 28, 2012

Oct 31 12

Actinogen Limited., Annual General Meeting, Nov 28, 2012., at 09:30 W. Australia Standard Time. Location: The Goodearth Hotel. Agenda: To receive and consider the balance sheet, income statement, statements of changes in equity and cash flows, and the reports of the directors and of the auditors for the year ended June 30, 2012; to consider adopt the remuneration report for the year ended June 30, 2012; to re-elect David Zohar and Alan Morton as Directors; and to deal with any other business which may be brought forward in accordance with the Constitution and the Corporations Act.